BlackRock Group’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$7.52M Buy
95,487
+37,097
+64% +$2.88M ﹤0.01% 996
2016
Q3
$4.55M Buy
58,390
+11,200
+24% +$813K ﹤0.01% 1151
2016
Q2
$3.24M Buy
47,190
+4,360
+10% +$301K ﹤0.01% 1280
2016
Q1
$3.06M Buy
42,830
+3,701
+9% +$232K ﹤0.01% 1287
2015
Q4
$2.43M Buy
39,129
+3,627
+10% +$221K ﹤0.01% 1382
2015
Q3
$2.01M Buy
35,502
+3,663
+12% +$194K ﹤0.01% 1494
2015
Q2
$1.71M Buy
31,839
+6,743
+27% +$328K ﹤0.01% 1640
2015
Q1
$1.19M Buy
25,096
+1,683
+7% +$74.5K ﹤0.01% 1774
2014
Q4
$1.01M Sell
23,413
-1,137
-5% -$46.5K ﹤0.01% 1862
2014
Q3
$844K Buy
24,550
+59
+0.2% +$2.08K ﹤0.01% 1884
2014
Q2
$897K Sell
24,491
-2,832
-10% -$96.1K ﹤0.01% 1900
2014
Q1
$922K Sell
27,323
-4,118
-13% -$136K ﹤0.01% 2021
2013
Q4
$1.07M Buy
31,441
+5,181
+20% +$179K ﹤0.01% 1932
2013
Q3
$836K Buy
26,260
+6,487
+33% +$173K ﹤0.01% 2007
2013
Q2
$447K Buy
+19,773
New +$428K ﹤0.01% 2083

Other funds holding CMD

BlackRock Group's CMD Position: Q4 2016 in Review

BlackRock Group increased its Cantel Medical Corporation (CMD) stake by 64% in Q4 2016, buying an estimated $2.88M and bringing the position to 95,487 shares worth $7.52M. The position accounts for ﹤0.01% of the portfolio, ranked #996.

BlackRock Group first reported a position in CMD in Q2 2013 and has held it in 15 quarters since. 234 funds tracked by Wall St. Rank hold CMD as of Q4 2016.

  • BlackRock Group held 95,487 shares of Cantel Medical Corporation worth $7.52M as of Q4 2016.
  • BlackRock Group bought 37,097 Cantel Medical Corporation shares in Q4 2016, an estimated $2.88M.
  • Cantel Medical Corporation made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #996 holding.
  • BlackRock Group first reported a position in Cantel Medical Corporation in Q2 2013 and has held it in 15 quarters since.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.